FDA Approved: XCOPRI — Original Application (SK Life Science, Inc.)

View source ↗

Summary

FDA approved XCOPRI (cenobamate) from SK Life Science, Inc. in an original NDA for adjunctive treatment of partial-onset seizures in adults with epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Xcopri (cenobamate)

Snippet

ORIG AP for XCOPRI (CENOBAMATE)